These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1779 related articles for article (PubMed ID: 33734962)

  • 41. Development of a unit conversion tool for five quantitative anti-spike assays and agreement analysis of three qualitative anti-nucleocapsid assays for SARS-CoV-2.
    Ouoba S; Sugiyama A; Ko K; Mirzaev UK; Abe K; E B; Phyo Z; Khalilov KK; Kurisu A; Akita T; Takahashi K; Sasaki H; Yamamoto T; Tanaka J
    J Med Virol; 2024 Aug; 96(8):e29826. PubMed ID: 39056254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion.
    Conzentino MS; Forchhammer K; Souza EM; Pedrosa FO; Nogueira MB; Raboni SM; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Fornazari B; Morales HMP; Celedon PAF; Lima CVP; Mattar SB; Lin VH; Morello LG; Marchini FK; Reis RA; Huergo LF
    Braz J Microbiol; 2021 Dec; 52(4):2069-2073. PubMed ID: 34342836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical Center.
    Carter RE; Theel ES; Breeher LE; Swift MD; Van Brunt NA; Smith WR; Blanchfield LL; Daugherty EA; Chapital AB; Matson KM; Bews KA; Johnson PW; Domnick RA; Joyce DE; Geyer HL; Granger D; Hilgart HR; Turgeon CT; Sanders KA; Matern D; Nassar A; Sampathkumar P; Hainy CM; Orford RR; Vachon CM; Didehban R; Morice WG; Ting HH; Williams AW; Gray RJ; Thielen KR; Farrugia G;
    Mayo Clin Proc; 2021 May; 96(5):1165-1174. PubMed ID: 33958053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients.
    Del Zompo F; De Maio F; Santopaolo F; Ricci R; Gasbarrini A; Pompili M; Ponziani FR
    Dig Liver Dis; 2021 May; 53(5):541-544. PubMed ID: 33707148
    [No Abstract]   [Full Text] [Related]  

  • 45. SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India.
    Kumar A; Sathyapalan D; Ramachandran A; Subhash K; Biswas L; Beena KV
    Clin Microbiol Infect; 2021 Mar; 27(3):481-483. PubMed ID: 32949718
    [No Abstract]   [Full Text] [Related]  

  • 46. Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips.
    Xie C; Ding H; Ding J; Xue Y; Lu S; Lv H
    J Med Virol; 2022 Apr; 94(4):1633-1640. PubMed ID: 34904253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit.
    Canas JJ; Starr MC; Hooks J; Arregui S; Wilson AC; Carroll AE; Saxena V; Amanat F; Krammer F; Fill J; Schade A; Chambers A; Schneider J; Schwaderer AL; Hains DS
    Kidney Int; 2021 Feb; 99(2):484-486. PubMed ID: 33509357
    [No Abstract]   [Full Text] [Related]  

  • 48. Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study.
    Rashid-Abdi M; Krifors A; Sälléber A; Eriksson J; Månsson E
    Infect Dis (Lond); 2021 Mar; 53(3):169-175. PubMed ID: 33232190
    [No Abstract]   [Full Text] [Related]  

  • 49. [Not Available].
    Béguelin A
    Rev Med Suisse; 2021 Jan; 17(723):234. PubMed ID: 33507668
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
    Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
    Choe PG; Kang CK; Suh HJ; Jung J; Song KH; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Park WB; Oh MD
    Emerg Infect Dis; 2021 Jan; 27(1):327-9. PubMed ID: 33050983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical company.
    Moroni-Zentgraf PC; Keller C; Mahmoudi M; Kallsen K; Eschenfelder CC; Sigmund R; Müller HW; Baum P; Boos B; Schneider M; Mundt E
    Curr Med Res Opin; 2021 Jun; 37(6):939-947. PubMed ID: 33836626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes.
    Jia X; Gesualdo P; Geno Rasmussen C; Alkanani AA; He L; Dong F; Rewers MJ; Michels AW; Yu L
    Diabetes Technol Ther; 2021 Jul; 23(7):517-521. PubMed ID: 33544017
    [No Abstract]   [Full Text] [Related]  

  • 54. Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.
    Xiong L; Li Q; Cao X; Xiong H; Huang M; Yang F; Liu Q; Meng D; Zhou M; Wang G; Tong J; Chen T; Zhang Y; He X; Fan Y; Zhang Y; Tang L; Jin Y; Xia J; Hu Y
    BMC Med; 2021 Jul; 19(1):163. PubMed ID: 34256745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
    Laing ED; Weiss CD; Samuels EC; Coggins SA; Wang W; Wang R; Vassell R; Sterling SL; Tso MS; Conner T; Goguet E; Moser M; Jackson-Thompson BM; Illinik L; Davies J; Ortega O; Parmelee E; Hollis-Perry M; Maiolatesi SE; Wang G; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Lindrose AR; Duplessis CA; Tribble DR; Malloy AMW; Burgess TH; Pollett SD; Olsen CH; Broder CC; Mitre E
    Emerg Infect Dis; 2022 Apr; 28(4):828-832. PubMed ID: 35203111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Orthogonal antibody testing for COVID-19 among healthcare workers in a non-epidemic place and time:Japan's Iwate Prefecture, May 18-31, 2020.
    Nakamura A; Sato R; Ando S; Oana N; Nozaki E; Endo H; Miyate Y; Soma J; Miyata G
    Fukushima J Med Sci; 2021 Apr; 67(1):27-32. PubMed ID: 33642419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A high-throughput multiplexed microfluidic device for COVID-19 serology assays.
    Rodriguez-Moncayo R; Cedillo-Alcantar DF; Guevara-Pantoja PE; Chavez-Pineda OG; Hernandez-Ortiz JA; Amador-Hernandez JU; Rojas-Velasco G; Sanchez-Muñoz F; Manzur-Sandoval D; Patino-Lopez LD; May-Arrioja DA; Posadas-Sanchez R; Vargas-Alarcon G; Garcia-Cordero JL
    Lab Chip; 2021 Jan; 21(1):93-104. PubMed ID: 33319882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
    Hartley GE; Edwards ESJ; Aui PM; Varese N; Stojanovic S; McMahon J; Peleg AY; Boo I; Drummer HE; Hogarth PM; O'Hehir RE; van Zelm MC
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33443036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients.
    Chen Y; Tong X; Wang J; Huang W; Yin S; Huang R; Yang H; Chen Y; Huang A; Liu Y; Chen Y; Yuan L; Yan X; Shen H; Wu C
    J Infect; 2020 Sep; 81(3):420-426. PubMed ID: 32504745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.